0001209191-18-038946.txt : 20180621 0001209191-18-038946.hdr.sgml : 20180621 20180621162443 ACCESSION NUMBER: 0001209191-18-038946 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180619 FILED AS OF DATE: 20180621 DATE AS OF CHANGE: 20180621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Goldman Steven M. CENTRAL INDEX KEY: 0001568216 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38135 FILM NUMBER: 18912077 MAIL ADDRESS: STREET 1: C/O DOVA PHARMACEUTICALS, INC. STREET 2: 240 LEIGH FARM ROAD, SUITE 245 CITY: DURHAM STATE: NC ZIP: 27707 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dova Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001685071 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813858961 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2530 MERIDIAN PARKWAY STREET 2: SUITE 300 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919-806-4487 MAIL ADDRESS: STREET 1: 2530 MERIDIAN PARKWAY STREET 2: SUITE 300 CITY: DURHAM STATE: NC ZIP: 27713 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-19 0 0001685071 Dova Pharmaceuticals, Inc. DOVA 0001568216 Goldman Steven M. C/O DOVA PHARMACEUTICALS, INC. 240 LEIGH FARM ROAD, SUITE 245 DURHAM NC 27707 1 0 0 0 Stock Option (Right to Buy) 30.11 2018-06-19 4 A 0 10000 0.00 A 2028-06-19 Common Stock 10000 10000 D The shares subject to the option will vest in equal monthly installments over the 12 months commencing on July 19, 2018, provided that the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. /s/Darren DeStefano, Attorney-in-Fact 2018-06-21